Calidi Biotherapeutics CLDI
NYSE CLDI
$1.34 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

Calidi Biotherapeutics (CLDI) Debt Ratio (2022 - 2025)

Calidi Biotherapeutics (CLDI) posted quarterly Debt Ratio of 0.02 for Q4 2025, down 89.04% year-over-year from 0.21 in Q4 2024, and down 20.8% quarter-over-quarter from 0.03 in Q3 2025.

Calidi Biotherapeutics (CLDI) Debt Ratio (2022 - 2025) Analysis & Trends

Calidi Biotherapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.02 for Q4 2025.

  • In Q4 2025, Debt Ratio fell 89.04% year-over-year to 0.02; the TTM figure through Dec 2025 stood at 0.02 (down 89.04% YoY), while the FY2025 annual figure was 0.02, down 89.04% from the prior year.
  • Debt Ratio for Q4 2025 stood at 0.02, down from 0.03 in the prior quarter.
  • The five-year high for Debt Ratio was 3.31 in Q3 2023, with the low at 0.02 in Q4 2025.
  • The 4-year median for Debt Ratio is 0.21 (2024), against an average of 0.55.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio climbed 0.24% in 2024, then plunged 93.26% in 2025.
  • Calidi Biotherapeutics' Debt Ratio stood at 0.96 in 2022, then plunged by 78.64% to 0.21 in 2023, then climbed by 0.24% to 0.21 in 2024, then tumbled by 89.04% to 0.02 in 2025.
  • Business Quant data shows CLDI's Debt Ratio at 0.02 in Q4 2025, 0.03 in Q3 2025, and 0.09 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Calidi Biotherapeutics 1.88 Mn -2.22 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.02
Sep 30, 2025 0.03
Jun 30, 2025 0.09
Mar 31, 2025 0.07
Dec 31, 2024 0.21
Sep 30, 2024 0.42
Jun 30, 2024 0.42
Mar 31, 2024 0.37
Dec 31, 2023 0.21
Sep 30, 2023 3.31
Dec 31, 2022 0.96